Table 2.
Summary table for the German NBS data with details about region and years included.
| Disorder screened | Region (years reported) | Number with disorder | Number screened | Incidence |
|---|---|---|---|---|
| MSUD | South-West Germany (1998–2014) | 14 | 1,674,021 | 1/119,573 |
| MSUD | Germany (2000–2014)a | 51 | 9,076,891 | 1/177,978 |
| PA | South-West Germany (1998–2004) | 2 | 568,901 | 1/284,450 |
| PA | Germany (2000–2004)a | 11 | 2,228,782 | 1/202,617 |
| MMA | South-West Germany (1998–2004) | 1 | 568,901 | 1/568,901 |
| MMA including cobalamin C/D | South-West Germany (1998–2004) | 5 | 568,901 | 1/113,780 |
| MMA and PA together, and including cobalamin C/D | South-West Germany (1998–2004) | 7 | 568,901 | 1/81,272 |
| MMA | Germany (2000–2004)a | 14 | 2,228,782 | 1/159,199 |
| MMA and PA together, and including cobalamin C/D # | Germany (2000–2004)a | 33 | 2,228,782 | 1/67,539 |
a
No data available for the year 2003; # including 6 cases with undifferentiated report of PA/MMA/Cbl from the year 2004 not included in the respective categories for Germany above.